top of page
LONGEVITY INDUSTRY 1.0
Roundtable Clips
Longevity Industry 1.0 Guest Author
Roundtable Clips
Robin on Meeting Dmitry & Kate
Robin Shares Her Personal Journey
Why is the USA's Healthy Longevity Gap ?
About Longevity Clinical Trial Failure Rate
What Robin Is Working On Right Now
Governments Prioritizing Longevity
Longevity Industry in California
AgeTech & the "7th Continent"
Health as New Wealth and What is Longevity FinTech?
Why Are FinTech Companies Ignoring Longevity?
Longevity Card Project: The Longevity Marketplace
Longevity Fintech in the Post Pandemic World
Is COVID-19 Fueling Longevity Industry Growth?
De-Risking Longevity Industry Investment
Longevity Industry Trials & Validation
Dmitry on Meeting Robin
The Rise of Longevity Industry ETFs, Stock Exchange
FinTech 2 0 and the The Integration of AgeTech
What is Longevity Card?
How Longevity Card is Fighting Ageism
The Longevity Industry's Evolution
Longevity Analytics 2.0
Biomarkers of Longevity
Practical Longevity
$1 Million - for the 1st Person to Reach 123 Years
Artificial Intelligence in Longevity
Robin and Kate on the Intersection of Longevity
Robin & Dmitry on Living to 120
Robin & Kate on the Ethics of Longevity
Technologies To Accelerate Drug Development
Dmitry Kaminskiy on Longevity NeuroTech
AgeTech, Longevity FinTech & Ageism
How to Democratize Longevity?
Robin and Dmitry on the Ethics of Longevity
Countries Competing to Become Longevity Industry Hubs
Longevity Industry 1.0 - Guest Author Roundtable
Biomarkers of Longevity
bottom of page